[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100540342":3},{"organization":4,"armGroups":7,"interventions":14,"overallOfficials":19,"centralContacts":24,"locations":30,"responsibleParty":58,"collaborators":60,"id":66,"slug":10,"hasResults":67,"nctId":68,"briefTitle":69,"officialTitle":69,"acronym":10,"eligibilityCriteria":70,"healthyVolunteers":71,"sex":72,"minAge":73,"maxAge":10,"enrollmentInfo":74,"targetDuration":10,"studyType":77,"phases":10,"briefSummary":78,"conditions":79,"keywords":10,"overallStatus":46,"whyStopped":10,"lastUpdateSubmitDate":81,"lastUpdatePostDateStruct":82,"startDateStruct":85,"completionDateStruct":87,"leadSponsor":89,"locationsCount":90},{"fullName":5,"class":6},"Mayo Clinic","OTHER",[8],{"label":9,"type":10,"description":11,"interventionNames":12},"Observational",null,"Participants undergo a non-contrast MRI on study and may optionally undergo a second non-contrast MRI on study. Participants may also undergo blood sample collection on study.",[13],"Other: Non-Interventional Study",[15],{"type":6,"name":16,"description":17,"armGroupLabels":18,"otherNames":10},"Non-Interventional Study","Non-interventional study",[9],[20],{"name":21,"affiliation":22,"role":23},"Stephen J. Riederer, PhD","Mayo Clinic in Rochester","PRINCIPAL_INVESTIGATOR",[25],{"name":26,"role":27,"phone":28,"phoneExt":10,"email":29},"Clinical Trials Referral Office","CONTACT","855-776-0015","mayocliniccancerstudies@mayo.edu",[31,45],{"facility":32,"status":33,"city":34,"state":35,"zip":36,"country":37,"countryCode":38,"cosmosGeoPoint":39,"geoPoint":44,"contacts":10},"Mayo Clinic in Arizona","ACTIVE_NOT_RECRUITING","Scottsdale","Arizona","85259","United States","US",{"type":40,"coordinates":41},"Point",[42,43],-111.89903,33.50921,{"lat":43,"lon":42},{"facility":22,"status":46,"city":47,"state":48,"zip":49,"country":37,"countryCode":38,"cosmosGeoPoint":50,"geoPoint":54,"contacts":55},"RECRUITING","Rochester","Minnesota","55905",{"type":40,"coordinates":51},[52,53],-92.4699,44.02163,{"lat":53,"lon":52},[56,57],{"name":26,"role":27,"phone":28,"phoneExt":10,"email":10},{"name":21,"role":23,"phone":10,"phoneExt":10,"email":10},{"type":59,"investigatorFullName":10,"investigatorTitle":10,"investigatorAffiliation":10,"oldNameTitle":10,"oldOrganization":10},"SPONSOR",[61,64],{"name":62,"class":63},"National Institute for Biomedical Imaging and Bioengineering (NIBIB)","NIH",{"name":65,"class":63},"National Cancer Institute (NCI)","100540342",false,"NCT06315595","Improvements in Dynamic Contrast-Enhanced MR Angiography and Perfusion and Non-Contrast MRI","Inclusion Criteria:\n\n* Adults\n\nExclusion Criteria:\n\n* Standard exclusion criteria for clinical MRI; e.g. cardiac pacemaker, claustrophobia, an implanted device that has been determined to be MR conditional at 1.5T but not at 3T, anticipated considerable susceptibility artifact from hip prosthesis, etc.",true,"ALL","18 Years",{"count":75,"type":76},1000,"ESTIMATED","OBSERVATIONAL","This study evaluates if technical improvements in MRI can be used to provide improved performance contrast-enhanced MRI as used for angiography and perfusion as well as in non-contrast MRI.",[80],"Prostate Neoplasm","2026-04-14",{"date":83,"type":84},"2026-04-17","ACTUAL",{"date":86,"type":84},"2015-09-30",{"date":88,"type":76},"2030-09-30",{"name":5,"class":6},2]